• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者中抑郁的发生:基于人群的巢式病例对照研究。

Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control study.

机构信息

Gastroenterology, St George's University of London, London, UK.

School of Primary Care and Public Health, Imperial College, London, UK.

出版信息

Gut. 2021 Sep;70(9):1642-1648. doi: 10.1136/gutjnl-2020-322308. Epub 2020 Oct 27.

DOI:10.1136/gutjnl-2020-322308
PMID:33109601
Abstract

OBJECTIVE

Depression is a potential risk factor for developing IBD. This association may be related to GI symptoms occurring before diagnosis. We aimed to determine whether depression, adjusted for pre-existing GI symptoms, is associated with subsequent IBD.

DESIGN

We conducted a nested case-control study using the Clinical Practice Research Datalink identifying incident cases of UC and Crohn's disease (CD) from 1998 to 2016. Controls without IBD were matched for age and sex. We measured exposure to prevalent depression 4.5-5.5 years before IBD diagnosis. We created two sub-groups with prevalent depression based on whether individuals had reported GI symptoms before the onset of depression. We used conditional logistic regression to derive ORs for the risk of IBD depending on depression status.

RESULTS

We identified 10 829 UC cases, 4531 CD cases and 15 360 controls. There was an excess of prevalent depression 5 years before IBD diagnosis relative to controls (UC: 3.7% vs 2.7%, CD 3.7% vs 2.9%). Individuals with GI symptoms prior to the diagnosis of depression had increased adjusted risks of developing UC and CD compared with those without depression (UC: OR 1.47, 95% CI 1.21 to 1.79; CD: OR 1.41, 95% CI 1.04 to 1.92). Individuals with depression alone had similar risks of UC and CD to those without depression (UC: OR 1.13, 95% CI 0.99 to 1.29; CD: OR 1.12, 95% CI 0.91 to 1.38).

CONCLUSIONS

Depression, in the absence of prior GI symptoms, is not associated with subsequent development of IBD. However, depression with GI symptoms should prompt investigation for IBD.

摘要

目的

抑郁是发生 IBD 的潜在危险因素。这种关联可能与诊断前发生的胃肠道症状有关。我们旨在确定在调整了预先存在的胃肠道症状后,抑郁是否与随后发生的 IBD 相关。

设计

我们使用临床实践研究数据链进行了一项嵌套病例对照研究,从 1998 年到 2016 年确定了 UC 和克罗恩病 (CD) 的新发病例。没有 IBD 的对照组按年龄和性别匹配。我们测量了在 IBD 诊断前 4.5-5.5 年内普遍存在的抑郁的暴露情况。我们根据个体在抑郁发作前是否报告过胃肠道症状,创建了两个基于普遍存在的抑郁的亚组。我们使用条件逻辑回归来获得取决于抑郁状态的 IBD 风险的 OR。

结果

我们确定了 10829 例 UC 病例、4531 例 CD 病例和 15360 例对照。与对照组相比,IBD 诊断前 5 年存在抑郁的情况更为普遍(UC:3.7%比 2.7%,CD:3.7%比 2.9%)。与没有抑郁的人相比,在诊断为抑郁之前有胃肠道症状的人患 UC 和 CD 的调整后风险增加(UC:OR 1.47,95%CI 1.21-1.79;CD:OR 1.41,95%CI 1.04-1.92)。仅患有抑郁的个体患 UC 和 CD 的风险与没有抑郁的个体相似(UC:OR 1.13,95%CI 0.99-1.29;CD:OR 1.12,95%CI 0.91-1.38)。

结论

在没有先前胃肠道症状的情况下,抑郁与随后发生的 IBD 无关。然而,有胃肠道症状的抑郁应该提示对 IBD 进行调查。

相似文献

1
Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control study.炎症性肠病患者中抑郁的发生:基于人群的巢式病例对照研究。
Gut. 2021 Sep;70(9):1642-1648. doi: 10.1136/gutjnl-2020-322308. Epub 2020 Oct 27.
2
Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression.抑郁症增加了炎症性肠病的风险,而使用抗抑郁药物治疗抑郁症可能会减轻这种风险。
Gut. 2019 Sep;68(9):1606-1612. doi: 10.1136/gutjnl-2018-317182. Epub 2018 Oct 18.
3
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.炎症性肠病的癌症风险:一项为期 6 年的前瞻性多中心巢式病例对照 IG-IBD 研究。
Inflamm Bowel Dis. 2020 Feb 11;26(3):450-459. doi: 10.1093/ibd/izz155.
4
Awareness of smoking in adolescents with inflammatory bowel disease.炎症性肠病青少年的吸烟知晓情况。
Ann Agric Environ Med. 2020 Mar 17;27(1):61-65. doi: 10.26444/aaem/105821. Epub 2019 Apr 8.
5
Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.炎症性肠病患者胃肠道报告结局测量信息系统(GI-PROMIS)症状量表的评估。
Am J Gastroenterol. 2018 Jan;113(1):72-79. doi: 10.1038/ajg.2017.240. Epub 2017 Aug 29.
6
Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.炎症性肠病与小肠癌风险:来自丹麦和瑞典的一项基于人群的两国队列研究。
Gut. 2021 Feb;70(2):297-308. doi: 10.1136/gutjnl-2020-320945. Epub 2020 May 30.
7
Population-based cases control study of inflammatory bowel disease risk factors.基于人群的病例对照研究炎症性肠病的危险因素。
J Gastroenterol Hepatol. 2010 Feb;25(2):325-33. doi: 10.1111/j.1440-1746.2009.06140.x. Epub 2010 Jan 14.
8
Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.显微镜结肠炎与全国队列研究中炎症性肠病的风险。
Gastroenterology. 2020 May;158(6):1574-1583.e2. doi: 10.1053/j.gastro.2019.12.028. Epub 2020 Jan 8.
9
Association between inflammatory bowel disease and subsequent depression or anxiety disorders - A retrospective cohort study of 31,728 outpatients.炎症性肠病与后续抑郁或焦虑症之间的关联——一项对31728名门诊患者的回顾性队列研究。
J Psychiatr Res. 2024 Jan;169:231-237. doi: 10.1016/j.jpsychires.2023.11.026. Epub 2023 Nov 22.
10
The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence.应激在炎症性肠病发生发展及临床过程中的作用:流行病学证据
Curr Mol Med. 2008 Jun;8(4):247-52. doi: 10.2174/156652408784533832.

引用本文的文献

1
Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study.炎症性肠病患者的疼痛与镇静药物使用:一项基于全国人口的队列研究
Aliment Pharmacol Ther. 2025 Oct;62(7):732-742. doi: 10.1111/apt.70247. Epub 2025 Jul 2.
2
Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health.炎症性肠病的环境风险因素:迈向预防性健康策略
J Crohns Colitis. 2025 Apr 4;19(4). doi: 10.1093/ecco-jcc/jjaf042.
3
Understanding Predictors of Crohn's Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn's Disease.
了解克罗恩病的预测因素:克罗恩病发病前期屏障功能改变的决定因素
J Can Assoc Gastroenterol. 2024 Jan 20;7(1):68-77. doi: 10.1093/jcag/gwad052. eCollection 2024 Feb.
4
Research on the correlation between inflammatory bowel disease and depression: A bibliometric analysis.炎症性肠病与抑郁症相关性的研究:一项文献计量分析。
Medicine (Baltimore). 2024 Dec 20;103(51):e40414. doi: 10.1097/MD.0000000000040414.
5
Gut microbial and human genetic signatures of inflammatory bowel disease increase risk of comorbid mental disorders.炎症性肠病的肠道微生物和人类基因特征会增加共病精神障碍的风险。
NPJ Genom Med. 2024 Oct 29;9(1):52. doi: 10.1038/s41525-024-00440-w.
6
Association between depression and anxiety with the risk and flare of inflammatory bowel disease: a systematic review and meta-analysis.抑郁症和焦虑症与炎症性肠病的风险及发作之间的关联:一项系统评价和荟萃分析。
Intern Emerg Med. 2025 Jan;20(1):35-46. doi: 10.1007/s11739-024-03764-8. Epub 2024 Oct 3.
7
Role of stress and early-life stress in the pathogeny of inflammatory bowel disease.应激及早期生活应激在炎症性肠病发病机制中的作用。
Front Neurosci. 2024 Sep 10;18:1458918. doi: 10.3389/fnins.2024.1458918. eCollection 2024.
8
The Role of Environmental and Nutritional Factors in the Development of Inflammatory Bowel Diseases: A Case-Control Study.环境和营养因素在炎症性肠病发展中的作用:病例对照研究。
Nutrients. 2024 Jul 29;16(15):2463. doi: 10.3390/nu16152463.
9
Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential.氯胺酮在抑郁症及相关疾病治疗中的新用途:最新进展与未来潜力
Aging Dis. 2024 Apr 29;16(2):804-840. doi: 10.14336/AD.2024.0239.
10
Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study.在炎症性肠病中,先前的医疗保健使用、诊断时间和临床结果之间的关联:一项具有全国代表性的基于人群的队列研究。
BMJ Open Gastroenterol. 2024 May 27;11(1):e001371. doi: 10.1136/bmjgast-2024-001371.